UF researchers test novel drug to slow Type 1 diabetes

Armed with a new $5.5 million grant from Breakthrough T1D, University of Florida researchers led by Dr. Michael Haller are launching a clinical trial to test whether SAB-142 can safely slow the progression of Type 1 diabetes. He joined FOX 35's Garrett Wymer live over Zoom to discuss his research.